Australasian multicentre phase II study of paclitaxel (Taxol*) in relapsed ovarian cancer
Author:
Publisher
Wiley
Subject
Internal Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1445-5994.1995.tb01899.x/fullpdf
Reference28 articles.
1. Cancer Statistics 1991;Boring;CA. Cancer J Clin,1991
2. Improved therapeutic index of carboplatin plus cyclophosphamide versus cisplatin plus cyclophosphamide: Final report by the Southwest Oncology Group of a phase III randomized trial in stages III and IV ovarian cancer;Alberts;J Clin Oncol,1992
3. Cisplatin-cyclophosphamide versus carboplatin-cyclophosphamide in advanced ovarian cancer: a randomized phase III study of the National Cancer Institute of Canada Clinical Trials Group;Swenerton;J Clin Oncol,1992
4. Long-term survival in ovarian cancer: Mature data from the Netherlands Joint Study Group for Ovarian Cancer;Neijt;Eur J Cancer,1991
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Taxane monotherapy regimens for the treatment of recurrent epithelial ovarian cancer;Cochrane Database of Systematic Reviews;2022-07-12
2. Paclitaxel-Loaded TPGS2k/Gelatin-Grafted Cyclodextrin/Hyaluronic Acid-Grafted Cyclodextrin Nanoparticles for Oral Bioavailability and Targeting Enhancement;Journal of Pharmaceutical Sciences;2022-06
3. A systematic review of platinum and taxane resistance from bench to clinic: An inverse relationship;Cancer Treatment Reviews;2007-12
4. Randomized Trial of Single Agent Paclitaxel Given Weekly Versus Every Three Weeks and with Peroral Versus Intravenous Steroid Premedication to Patients with Ovarian Cancer Previously Treated with Platinum;Acta Oncologica;2002-01
5. Multicenter phase II study of gemcitabine in previously untreated patients with advanced epithelial ovarian cancer;Anti-Cancer Drugs;2001-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3